Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells

Natural killer (NK) cells have an intrinsic ability to detect and eliminate leukaemic cells. Cellular therapies using cytokine-activated NK cells have emerged as promising treatments for patients with advanced leukaemia. However, not all patients respond to current NK cell therapies, and thus improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Samantha A., Audsley, Katherine M., Newnes, Hannah V., Fernandez, Sonia, de Jong, Emma, Waithman, Jason, Foley, Bree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731670/
https://www.ncbi.nlm.nih.gov/pubmed/36505400
http://dx.doi.org/10.3389/fimmu.2022.1050718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731670/
https://www.ncbi.nlm.nih.gov/pubmed/36505400
http://dx.doi.org/10.3389/fimmu.2022.1050718

Ejemplares similares